Candriam S.C.A. - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$1,553,000
-2.3%
149,466
+0.0%
0.02%0.0%
Q4 2019$1,589,000
+33.9%
149,438
+31.1%
0.02%
+6.2%
Q3 2019$1,187,000
-2.7%
114,000
+42.5%
0.02%
+6.7%
Q2 2019$1,220,000
-53.3%
80,000
-67.2%
0.02%
-75.0%
Q4 2016$2,611,000
-6.2%
244,000
-5.1%
0.06%
-10.4%
Q3 2016$2,783,000257,0000.07%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders